Ganglioside GM2: a potential biomarker for cholangiocarcinoma.

Krajang TalabninChutima TalabninTadahiro KumagaiNuchanard SutatumJuthamas KhiaowichitChawaboon DechsukhumMayumi IshiharaParastoo AzadiBanchob Sripa

Published in: The Journal of international medical research (2021)

Altered expression of glycosphingolipids in tissue and serum from patients with cholangiocarcinoma may contribute to tumor growth and progression. The ganglioside GM2, which significantly increased in the serum of patients with cholangiocarcinoma, represents a promising target as a biomarker for cholangiocarcinoma.

Keyphrases

poor prognosis
binding protein
long non coding rna